Tag: Cancer: Skin
Risk for Melanoma Reduced for Individuals With Atopy
Fewer cases of melanoma, lower investigator-estimated risk class of skin cancer observed in atopic versus nonatopic individuals
AAD: Risk for Skin Cancer Higher for Adults With Atopic Dermatitis
Significantly increased risk seen for adults with moderate-to-severe versus mild atopic dermatitis
Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients
No difference seen in keratinocyte cancers or actinic keratoses for organ-transplant recipients receiving oral nicotinamide or placebo
Neoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma
Event-free survival longer for those receiving neoadjuvant and adjuvant pembrolizumab versus adjuvant pembrolizumab only
Methotrexate Linked to Increased Risk for Skin Cancer
When restricting analysis to patients with psoriasis, methotrexate was only associated with basal cell carcinoma
Risk for Subsequent Facial Keratinocyte Carcinoma Lower With Laser Treatment
Nonablative fractional laser-treated patients had lower rate of subsequent facial keratinocyte carcinoma development
Regular Use of Vitamin D Linked to Fewer Melanoma Cases
Lower percentage of individuals seen with history of past or present melanoma, any type of skin cancer among regular users
MPATH-Dx Version 2.0 Simplifies Classification of Melanoma
Updated version simplifies original five-class hierarchy into four classes, including clearly defining classes I and II lesions
Survival Rates High for Children, Teens With Melanoma
Primary tumor ulceration, head/neck location, and Breslow thickness >4 mm predict worse survival in teens
Moderna, Merck Report on Promising Melanoma Vaccine
Companies announced that the vaccine performed well in a small study of patients who had the cancer surgically removed
